Multivariate approach of including different MR parameters offer a holistic view of entire data, which could provide better approach in differentiating various prostatic diseases. This approach may help in reducing the burden of unnecessary biopsy in men with PSA 4-10 ng/ml. we evaluated discriminatory ability of MRSI and DW-MRI in prostatic diseases in biopsy naïve men with PSA 4-10 ng/ml. The combined model (PSA + ADC + metabolite ratio) showed highest discriminatory ability in various prostatic diseases with AUC of 89% in men with clinically challenging group of PSA.
This abstract and the presentation materials are available to members only; a login is required.